Bristol Myers Squibb is expanding its laboratory in Leasowe, signaling growth in the UK’s life sciences sector, amidst AstraZeneca’s paused investment due to funding concerns.
The new BMS building will be 50% larger than its current facilities and is integral for product development, employing 250 staff, significantly boosting local scientific capacity.
Dr. Clare Rawlinson-Malone emphasizes the importance of collaboration with local universities for talent development, noting the sector's dynamism and enthusiasm for a regional approach.
BMS's commitment to sustainability includes using enzymes in drug synthesis, reducing reliance on oil-based solvents and heavy metals, reflecting a growing trend in responsible development.
Collection
[
|
...
]